Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion type Assertion NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_head.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion description "[The use of enoxacin in human cell cultures and xenografted, orthotopic, and metastatic mouse models reveals a TRBP-dependent and cancer-specific growth-inhibitory effect of the drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion evidence source_evidence_literature NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion SIO_000772 21368194 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion wasDerivedFrom befree-20140225 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.
- NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_assertion wasGeneratedBy ECO_0000203 NP651430.RA1YKu4A5763zZ-JvxXikdEZrZfRln5YVMTxbLkpFkc5k130_provenance.